Which hedge funds own RNA? ATRIUM THERAPEUTICS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in RNA (ATRIUM THERAPEUTICS INC) in their Q2 2026 13F filings, worth $5.8m in total. The largest holder by portfolio weight is Tudor Investment at 0.0% of its book. 1 manager opened a new position this quarter: Renaissance Technologies LLC. 6 exited: Farallon Capital Management, Marshall Wace, Pentwater Capital Management.
5tracked managers holding
1opened this quarter
6exited this quarter
Which hedge funds hold RNA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Tudor Investment | Q2 2026 | 0.0% | $1.7m | 129,591 | 82% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $280.2k | 20,834 | -34% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $2.7m | 200,559 | 5% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $909.7k | 67,639 | -38% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $201.4k | 14,971 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.2% | $4.7m |
| Marshall Wace | 0.0% | $450.4k |
| Pentwater Capital Management | 0.3% | $8.1m |
| Point72 Asset Management LP | 0.0% | $303.6k |
| RA Capital Management | 0.4% | $11.6m |
| Woodline Partners | 0.0% | $385.7k |
How has hedge fund ownership of RNA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $5.8m |
| Q1 2026 | 10 | $30.8m |
Counts every tracked manager that disclosed RNA in that quarter's filing, including managers that have since stopped filing.